Discover
ONC
BeOne Medicines AG
361.40
1 x 361.31
1 x 361.68
bid
ask
+
2.40
0.67%
12:36 PM
timesize
| Ytd | 18.95% | |
| 1y | 24.73% |
360.00
day range
366.97
253.95
52 week range
385.22
| Open | 361.61 | Prev Close | 359.00 | Low | 360.00 | High | 366.97 | Mkt Cap | 38.63B |
| Vol | 282.29K | Avg Vol | 331.77K | EPS | 5.68 | P/E | 63.65 | Forward P/E | 34.32 |
| Beta | 0.49 | Short Ratio | 2.80 | Inst. Own | 33.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 298.10 | 200-d Avg | 314.50 | 1yr Est | 431.70 |
| Income Statement | |||
| Total Revenue | 1.71B | ||
| Revenues (USD) | 1.71B | ||
| Cost of Revenue | 174.53M | ||
| Gross Profit | 1.53B | ||
| Operating Expenses | 1.21B | ||
| Research and Development Expense | 612.28M | ||
| Selling, General and Administrative Expense | 593.21M | ||
| Operating Income | 325.05M | ||
| Interest Expense | 39.74M | ||
| Income Tax Expense | 75.45M | ||
| Net Income | 237.01M | ||
| Net Income Common Stock | 237.01M | ||
| Net Income Common Stock (USD) | 237.01M | ||
| Consolidated Income | 237.01M | ||
| Earnings per Basic Share | 0.16 | ||
| Earnings per Basic Share (USD) | 0.16 | ||
| Earnings per Diluted Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 352.20M | ||
| Earning Before Interest & Taxes (USD) | 352.20M | ||
| Weighted Average Shares | 1.45B | ||
| Weighted Average Shares Diluted | 1.51B | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.10B | ||
| Cash and Equivalents (USD) | 5.10B | ||
| Trade and Non-Trade Receivables | 1.06B | ||
| Current Assets | 7.22B | ||
| Property, Plant & Equipment Net | 1.79B | ||
| Total Assets | 9.18B | ||
| Debt Current | 302.13M | ||
| Total Debt | 2.05B | ||
| Current Liabilities | 2.12B | ||
| Debt Non-Current | 1.75B | ||
| Total Liabilities | 4.00B | ||
| Accumulated Retained Earnings (Deficit) | -7.86B | ||
| Accumulated Other Comprehensive Income | -25.37M | ||
| Shareholders Equity | 5.17B | ||
| Shareholders Equity (USD) | 5.17B | ||
| Assets Non-Current | 1.96B | ||
| Total Debt (USD) | 2.05B | ||
| Goodwill and Intangible Assets | 60.96M | ||
| Inventory | 732.60M | ||
| Liabilities Non-Current | 1.88B | ||
| Trade and Non-Trade Payables | 470.30M | ||
| Tax Liabilities | 133.70M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 40.52M | ||
| Net Cash Flow from Financing | -6.05M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 427.25M | ||
| Capital Expenditure | -27.48M | ||
| Issuance (Purchase) of Equity Shares | 11.05M | ||
| Issuance (Repayment) of Debt Securities | -17.05M | ||
| Net Cash Flow from Investing | -49.35M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.85M | ||
| Net Cash Flow from Operations | 462.82M | ||
| Effect of Exchange Rate Changes on Cash | 19.84M | ||
| Share Based Compensation | 137.41M | ||